“…In Table 2, shared pathways with genes deregulated by VPA and downregulated in models of causative genes for KLEFS, KS, CHARGE, MRD1, and ARTHS or ICF1 are summarized (Katsumoto et al, 2006;Issaeva et al, 2007;Min et al, 2007;Fan, 2008;Gupta-Agarwal et al, 2012;Mansour et al, 2012;Balemans et al, 2014;Chen et al, 2014;Kim et al, 2014;Schulz et al, 2014;Turner-Ivey et al, 2014;Gigek et al, 2015;Dhar et al, 2016Dhar et al, , 2018Fang et al, 2016;Mullegama et al, 2016;Sheikh et al, 2016Sheikh et al, , 2017Feng et al, 2017a,b;Shpargel et al, 2017;Whittaker et al, 2017;Baell et al, 2018;Marie et al, 2018;Yao et al, 2018Yao et al, , 2020Carosso et al, 2019;Machado et al, 2019;Nowialis et al, 2019;Cieslar-Pobuda et al, 2020;Frega et al, 2020;Hsu et al, 2020;Kong et al, 2020;Liu et al, 2020;Xu et al, 2020;Ying et al, 2020;Fei et al, 2021;Lopusna et al, 2021). Of note, the most commonly shared pathways involve either morphogenesis signals (for example, beta1 integrin cell surface interactions and extracellular matrix organization), or possible defects of the central nervous system (such as axon guidance and neuro...…”